Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

Bioactivation and Tissue Toxicity

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...

Toxicity Testing in Animals

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...

Molecular Models

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

How viable are alternatives to animal testing in determining the toxicities of therapeutic drugs?

Expert opinion on drug metabolism & toxicology·2019

Same author

Electronic cigarettes: can dependable public health policies be developed and applied without relevant and reliable risk assessments?

Alternatives to laboratory animals : ATLA·2018

Same author

Questionable progress in the application of the Three Rs to improve science, human well-being and animal welfare.

Alternatives to laboratory animals : ATLA·2018

Same author

The replacement of animal tests.

Alternatives to laboratory animals : ATLA·2018

Same author

The use of in vivo, ex vivo, in vitro, computational models and volunteer studies in vision research and therapy, and their contribution to the Three Rs.

Alternatives to laboratory animals : ATLA·2016

Same author

On the safety of e-cigarettes: "I can resist anything except temptation".

Alternatives to laboratory animals : ATLA·2016

Search research articles

Related Experiment Video

Updated: May 31, 2026

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

Challenges for computational structure-activity modelling for predicting chemical toxicity: future improvements?

Robert D Combes¹

¹Consultant, Norwich, UK. robert_combes3@yahoo.co.uk

Expert Opinion on Drug Metabolism & Toxicology

|July 16, 2011

Summary

This summary is machine-generated.

Structure-activity modelling for toxicology prediction faces challenges. Improving model validation and characterising structure-activity landscapes are key to realizing computational toxicology's potential.

More Related Videos

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Related Experiment Videos

Last Updated: May 31, 2026

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Area of Science:

Computational toxicology and cheminformatics.
Quantitative structure-activity relationship (QSAR) modelling.

Background:

Structure-activity modelling for toxicology prediction is a 50-year-old discipline.
Computational toxicology offers potential for faster chemical screening and reduced conventional testing.
Realizing this potential is hindered by challenges in developing and validating toxicity models.

Purpose of the Study:

To discuss the inherent problems in developing and validating structure-activity models for toxicity.
To highlight areas for improvement in computational toxicology practices.

Main Methods:

Discussion of key issues in computational toxicology, including descriptor selection, activity cliffs, data quality, and validation strategies.
Review of limitations in current structure-activity modelling approaches.

Main Results:

Identified problems include non-transparent descriptors, activity cliffs, spurious correlations, data quality issues, challenges with novel chemical prediction, and over-reliance on complex statistics.
Current methods often lack robust validation for predicting novel chemical toxicity.

Conclusions:

Emphasize rigorous selection of training and test sets for robust internal and external model validation.
Incorporate advanced techniques for characterizing structure-activity landscapes to improve model interpretability and predictivity.